Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 19, 2013

View Archived Issues

Global Blood Therapeutics agent prevents sickling in sickle cell disease

Amgen reports topline results from phase III MENDEL-2 trial

to-BBB begins phase I study of 2B3-201 in healthy volunteers

Aquinox Pharmaceuticals begins phase II trial of AQX-1125 in COPD

Bioheart to begin AdipoCell study for dry macular degeneration

Vical begins phase I/II trial of a therapeutic HSV-2 vaccine

Endo Health Solutions to acquire NuPathe

Lilly joins Combinations Alliance to bring experimental molecules to clinical trials

CHRNA7 and CHRFAM7A gene expression linked to mental disorders

Stelis Biopharma and Pieris collaborate on Anticalin therapeutics in ophthalmology

ChemoCentryx develops CCR4 receptor antagonist for allergic diseases

Pfizer presents new Na(V)1.7 antagonist with promising activity in animal models of pain

Roche patents new Mdm2/p53 inhibitors for cancer

Novel antibodies for autoimmune disorders disclosed by German scientists

Sucampo and Takeda begin phase III program for lubiprostone in pediatric constipation

Takeda Pharmaceutical synthesizes novel PKR1 receptor antagonists

Onconova discontinues phase III study of rigosertib in pancreatic cancer

Researchers at Astex Pharmaceuticals present new FGFR inhibitors for cancer

FDA accepts supplemental BLA for Eylea in diabetic macular edema

Convergence Pharmaceuticals discloses new Na(V)1.7 blockers

GSK and Genmab receive FDA priority review for Arzerra BLA

BioLineRx begins phase I/II trial of BL-7010 in celiac disease

Preclinical and clinical studies evaluate ONO-4059 in B-cell malignancies, CLL

OMS-721 gains orphan status for complement-mediated thrombotic microangiopathies

Bayer HealthCare joins Structural Genomics Consortium for epigenetic research

FDA approves Anoro Ellipta for chronic obstructive pulmonary disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...